{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T20:38:41Z","timestamp":1789763921510,"version":"4.0.1"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2020,6,11]],"date-time":"2020-06-11T00:00:00Z","timestamp":1591833600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,6,11]],"date-time":"2020-06-11T00:00:00Z","timestamp":1591833600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100007086","name":"Pitt Hopkins Research Foundation","doi-asserted-by":"publisher","award":["N\/A"],"award-info":[{"award-number":["N\/A"]}],"id":[{"id":"10.13039\/100007086","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["3R43NS107079-01S1"],"award-info":[{"award-number":["3R43NS107079-01S1"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pharm Res"],"published-print":{"date-parts":[[2020,7]]},"DOI":"10.1007\/s11095-020-02853-5","type":"journal-article","created":{"date-parts":[[2020,6,11]],"date-time":"2020-06-11T21:02:33Z","timestamp":1591909353000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Repurposing the Dihydropyridine Calcium Channel Inhibitor Nicardipine as a Nav1.8 Inhibitor In Vivo for Pitt Hopkins Syndrome"],"prefix":"10.1007","volume":"37","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5691-5790","authenticated-orcid":false,"given":"Sean","family":"Ekins","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana C.","family":"Puhl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Audrey","family":"Davidow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,6,11]]},"reference":[{"issue":"4","key":"2853_CR1","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1007\/s11095-015-1841-9","volume":"33","author":"S Ekins","year":"2016","unstructured":"Ekins S, Wood J. Incentives for starting small companies focused on rare and neglected diseases. Pharm Res. 2016;33(4):809\u201315.","journal-title":"Pharm Res"},{"issue":"3","key":"2853_CR2","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1039\/C8MT00342D","volume":"11","author":"AG Dalecki","year":"2019","unstructured":"Dalecki AG, Zorn KM, Clark AM, Ekins S, Narmore WT, Tower N, et al. High-throughput screening and Bayesian machine learning for copper-dependent inhibitors of Staphylococcus aureus. Metallomics. 2019;11(3):696\u2013706.","journal-title":"Metallomics."},{"issue":"7\u20138","key":"2853_CR3","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.drudis.2011.02.016","volume":"16","author":"S Ekins","year":"2011","unstructured":"Ekins S, Williams AJ, Krasowski MD, Freundlich JS. In silico repositioning of approved drugs for rare and neglected diseases. Drug Discov Today. 2011;16(7\u20138):298\u2013310.","journal-title":"Drug Discov Today"},{"issue":"3","key":"2853_CR4","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/j.drudis.2018.01.018","volume":"23","author":"NC Baker","year":"2018","unstructured":"Baker NC, Ekins S, Williams AJ, Tropsha A. A bibliometric review of drug repurposing. Drug Discov Today. 2018;23(3):661\u201372.","journal-title":"Drug Discov Today"},{"issue":"2","key":"2853_CR5","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/j.drudis.2017.10.009","volume":"23","author":"B Delavan","year":"2018","unstructured":"Delavan B, Roberts R, Huang R, Bao W, Tong W, Liu Z. Computational drug repositioning for rare diseases in the era of precision medicine. Drug Discov Today. 2018;23(2):382\u201394.","journal-title":"Drug Discov Today"},{"issue":"24","key":"2853_CR6","doi-asserted-by":"crossref","first-page":"2764","DOI":"10.2174\/0929867324666170830101215","volume":"25","author":"E Valencic","year":"2018","unstructured":"Valencic E, Smid A, Jakopin Z, Tommasini A, Mlinaric-Rascan I. Repositioning drugs for rare immune diseases: hopes and challenges for a precision medicine. Curr Med Chem. 2018;25(24):2764\u201382.","journal-title":"Curr Med Chem"},{"issue":"3","key":"2853_CR7","first-page":"182","volume":"14","author":"D Pitt","year":"1978","unstructured":"Pitt D, Hopkins I. A syndrome of mental retardation, wide mouth and intermittent overbreathing. Aust Paediatr J. 1978;14(3):182\u20134.","journal-title":"Aust Paediatr J"},{"issue":"12","key":"2853_CR8","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1093\/hmg\/ddm099","volume":"16","author":"A Brockschmidt","year":"2007","unstructured":"Brockschmidt A, Todt U, Ryu S, Hoischen A, Landwehr C, Birnbaum S, et al. Severe mental retardation with breathing abnormalities (Pitt-Hopkins syndrome) is caused by haploinsufficiency of the neuronal bHLH transcription factor TCF4. Hum Mol Genet. 2007;16(12):1488\u201394.","journal-title":"Hum Mol Genet"},{"issue":"5","key":"2853_CR9","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1086\/515583","volume":"80","author":"C Zweier","year":"2007","unstructured":"Zweier C, Peippo MM, Hoyer J, Sousa S, Bottani A, Clayton-Smith J, et al. Haploinsufficiency of TCF4 causes syndromal mental retardation with intermittent hyperventilation (Pitt-Hopkins syndrome). Am J Hum Genet. 2007;80(5):994\u20131001.","journal-title":"Am J Hum Genet"},{"issue":"5","key":"2853_CR10","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1086\/515582","volume":"80","author":"J Amiel","year":"2007","unstructured":"Amiel J, Rio M, de Pontual L, Redon R, Malan V, Boddaert N, et al. Mutations in TCF4, encoding a class I basic helix-loop-helix transcription factor, are responsible for Pitt-Hopkins syndrome, a severe epileptic encephalopathy associated with autonomic dysfunction. Am J Hum Genet. 2007;80(5):988\u201393.","journal-title":"Am J Hum Genet"},{"issue":"4","key":"2853_CR11","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1111\/cge.13506","volume":"95","author":"M Zollino","year":"2019","unstructured":"Zollino M, Zweier C, Van Balkom ID, Sweetser DA, Alaimo J, Bijlsma EK, et al. Diagnosis and management in Pitt-Hopkins syndrome: First international consensus statement. Clin Genet. 2019;95(4):462\u201378.","journal-title":"Clin Genet"},{"issue":"8","key":"2853_CR12","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1038\/s41380-019-0353-0","volume":"24","author":"H Li","year":"2019","unstructured":"Li H, Zhu Y, Morozov YM, Chen X, Page SC, Rannals MD, et al. Disruption of TCF4 regulatory networks leads to abnormal cortical development and mental disabilities. Mol Psychiatry. 2019;24(8):1235\u201346.","journal-title":"Mol Psychiatry"},{"issue":"6","key":"2853_CR13","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0199359","volume":"13","author":"S Crux","year":"2018","unstructured":"Crux S, Herms J, Dorostkar MM. Tcf4 regulates dendritic spine density and morphology in the adult brain. PLoS One. 2018;13(6):e0199359.","journal-title":"PLoS One"},{"issue":"3","key":"2853_CR14","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1177\/0883073817750490","volume":"33","author":"K Goodspeed","year":"2018","unstructured":"Goodspeed K, Newsom C, Morris MA, Powell C, Evans P, Golla S. Pitt-Hopkins syndrome: a review of current literature, clinical approach, and 23-patient case series. J Child Neurol. 2018;33(3):233\u201344.","journal-title":"J Child Neurol"},{"issue":"7","key":"2853_CR15","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1038\/s41431-018-0096-4","volume":"26","author":"L Mary","year":"2018","unstructured":"Mary L, Piton A, Schaefer E, Mattioli F, Nourisson E, Feger C, et al. Disease-causing variants in TCF4 are a frequent cause of intellectual disability: lessons from large-scale sequencing approaches in diagnosis. Eur J Hum Genet. 2018;26(7):996\u20131006.","journal-title":"Eur J Hum Genet"},{"issue":"9","key":"2853_CR16","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1017\/S1355617718000668","volume":"24","author":"A Tan","year":"2018","unstructured":"Tan A, Goodspeed K, Edgar VB. Pitt-Hopkins syndrome: a unique case study. J Int Neuropsychol Soc. 2018;24(9):995\u20131002.","journal-title":"J Int Neuropsychol Soc"},{"issue":"10","key":"2853_CR17","doi-asserted-by":"crossref","first-page":"2666","DOI":"10.1016\/j.celrep.2016.08.004","volume":"16","author":"AJ Kennedy","year":"2016","unstructured":"Kennedy AJ, Rahn EJ, Paulukaitis BS, Savell KE, Kordasiewicz HB, Wang J, et al. Tcf4 regulates synaptic plasticity, DNA methylation, and memory function. Cell Rep. 2016;16(10):2666\u201385.","journal-title":"Cell Rep"},{"issue":"4","key":"2853_CR18","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1523\/JNEUROSCI.1305-17.2017","volume":"38","author":"C Thaxton","year":"2018","unstructured":"Thaxton C, Kloth AD, Clark EP, Moy SS, Chitwood RA, Philpot BD. Common pathophysiology in multiple mouse models of Pitt-Hopkins syndrome. J Neurosci. 2018;38(4):918\u201336.","journal-title":"J Neurosci"},{"issue":"1","key":"2853_CR19","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.neuron.2016.02.021","volume":"90","author":"MD Rannals","year":"2016","unstructured":"Rannals MD, Hamersky GR, Page SC, Campbell MN, Briley A, Gallo RA, et al. Psychiatric risk gene transcription factor 4 regulates intrinsic excitability of prefrontal neurons via repression of SCN10a and KCNQ1. Neuron. 2016;90(1):43\u201355.","journal-title":"Neuron."},{"issue":"1","key":"2853_CR20","volume":"4","author":"MD Rannals","year":"2016","unstructured":"Rannals MD, Page SC, Campbell MN, Gallo RA, Mayfield B, Maher BJ. Neurodevelopmental models of transcription factor 4 deficiency converge on a common ion channel as a potential therapeutic target for Pitt Hopkins syndrome. Rare Dis. 2016;4(1):e1220468.","journal-title":"Rare Dis"},{"issue":"6","key":"2853_CR21","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1080\/19336950.2015.1079674","volume":"9","author":"SK Bagal","year":"2015","unstructured":"Bagal SK, Marron BE, Owen RM, Storer RI, Swain NA. Voltage gated sodium channels as drug discovery targets. Channels (Austin). 2015;9(6):360\u20136.","journal-title":"Channels (Austin)"},{"issue":"4","key":"2853_CR22","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1124\/pr.57.4.5","volume":"57","author":"WA Catterall","year":"2005","unstructured":"Catterall WA, Perez-Reyes E, Snutch TP, Striessnig J. International Union of Pharmacology. XLVIII. Nomenclature and structure-function relationships of voltage-gated calcium channels. Pharmacol Rev. 2005;57(4):411\u201325.","journal-title":"Pharmacol Rev"},{"issue":"2","key":"2853_CR23","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1006\/geno.1998.5735","volume":"57","author":"NW Plummer","year":"1999","unstructured":"Plummer NW, Meisler MH. Evolution and diversity of mammalian sodium channel genes. Genomics. 1999;57(2):323\u201331.","journal-title":"Genomics."},{"issue":"2","key":"2853_CR24","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/S0304-3959(98)00120-1","volume":"78","author":"DK Rabert","year":"1998","unstructured":"Rabert DK, Koch BD, Ilnicka M, Obernolte RA, Naylor SL, Herman RC, et al. A tetrodotoxin-resistant voltage-gated sodium channel from human dorsal root ganglia, hPN3\/SCN10A. Pain. 1998;78(2):107\u201314.","journal-title":"Pain."},{"issue":"6562","key":"2853_CR25","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1038\/379257a0","volume":"379","author":"AN Akopian","year":"1996","unstructured":"Akopian AN, Sivilotti L, Wood JN. A tetrodotoxin-resistant voltage-gated sodium channel expressed by sensory neurons. Nature. 1996;379(6562):257\u201362.","journal-title":"Nature."},{"key":"2853_CR26","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1038\/9195","volume":"2","author":"ANSV Akopian","year":"1999","unstructured":"Akopian ANSV, England S, Okuse K, Ogata N, Ure J, Smith A, et al. The tetrodotoxin-resistant sodium channel SNS has a specialized function in pain pathways. Nat Neurosci. 1999;2:541\u20138.","journal-title":"Nat Neurosci"},{"issue":"3","key":"2853_CR27","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.pain.2007.07.026","volume":"131","author":"TR Cummins","year":"2007","unstructured":"Cummins TR, Sheets PL, Waxman SG. The roles of sodium channels in nociception: implications for mechanisms of pain. Pain. 2007;131(3):243\u201357.","journal-title":"Pain."},{"issue":"10","key":"2853_CR28","doi-asserted-by":"crossref","first-page":"1712","DOI":"10.1002\/cmdc.201200298","volume":"7","author":"A Nardi","year":"2012","unstructured":"Nardi A, Damann N, Hertrampf T, Kless A. Advances in targeting voltage-gated sodium channels with small molecules. ChemMedChem. 2012;7(10):1712\u201340.","journal-title":"ChemMedChem."},{"issue":"1","key":"2853_CR29","doi-asserted-by":"crossref","first-page":"14653","DOI":"10.1038\/s41598-017-15028-x","volume":"7","author":"ME Gurney","year":"2017","unstructured":"Gurney ME, Cogram P, Deacon RM, Rex C, Tranfaglia M. Multiple behavior phenotypes of the fragile-X syndrome mouse model respond to chronic inhibition of Phosphodiesterase-4D (PDE4D). Sci Rep. 2017;7(1):14653.","journal-title":"Sci Rep"},{"key":"2853_CR30","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.neuropharm.2018.05.004","volume":"147","author":"MR Tranfaglia","year":"2019","unstructured":"Tranfaglia MR, Thibodeaux C, Mason DJ, Brown D, Roberts I, Smith R, et al. Repurposing available drugs for neurodevelopmental disorders: the fragile X experience. Neuropharmacology. 2019;147:74\u201386.","journal-title":"Neuropharmacology."},{"issue":"3","key":"2853_CR31","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1038\/nprot.2006.170","volume":"1","author":"RM Deacon","year":"2006","unstructured":"Deacon RM. Assessing nest building in mice. Nat Protoc. 2006;1(3):1117\u20139.","journal-title":"Nat Protoc"},{"issue":"9","key":"2853_CR32","doi-asserted-by":"crossref","first-page":"eaau4139","DOI":"10.1126\/sciadv.aau4139","volume":"5","author":"A Doostparast Torshizi","year":"2019","unstructured":"Doostparast Torshizi A, Armoskus C, Zhang H, Forrest MP, Zhang S, Souaiaia T, et al. Deconvolution of transcriptional networks identifies TCF4 as a master regulator in schizophrenia. Sci Adv. 2019;5(9):eaau4139.","journal-title":"Sci Adv"},{"key":"2853_CR33","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.bbr.2014.07.023","volume":"273","author":"CS Pedersen","year":"2014","unstructured":"Pedersen CS, Sorensen DB, Parachikova AI, Plath N. PCP-induced deficits in murine nest building activity: employment of an ethological rodent behavior to mimic negative-like symptoms of schizophrenia. Behav Brain Res. 2014;273:63\u201372.","journal-title":"Behav Brain Res"},{"key":"2853_CR34","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.bbr.2016.06.058","volume":"313","author":"AM Tartaglione","year":"2016","unstructured":"Tartaglione AM, Armida M, Potenza RL, Pezzola A, Popoli P, Calamandrei G. Aberrant self-grooming as early marker of motor dysfunction in a rat model of Huntington's disease. Behav Brain Res. 2016;313:53\u20137.","journal-title":"Behav Brain Res"},{"issue":"6","key":"2853_CR35","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1016\/j.cell.2014.07.049","volume":"158","author":"W Hong","year":"2014","unstructured":"Hong W, Kim DW, Anderson DJ. Antagonistic control of social versus repetitive self-grooming behaviors by separable amygdala neuronal subsets. Cell. 2014;158(6):1348\u201361.","journal-title":"Cell."},{"issue":"20","key":"2853_CR36","doi-asserted-by":"crossref","first-page":"2552","DOI":"10.2174\/09298673113209990123","volume":"20","author":"B Hegyi","year":"2013","unstructured":"Hegyi B, Komaromi I, Nanasi PP, Szentandrassy N. Selectivity problems with drugs acting on cardiac Na(+) and Ca(2)(+) channels. Curr Med Chem. 2013;20(20):2552\u201371.","journal-title":"Curr Med Chem"},{"key":"2853_CR37","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.ejmech.2015.03.027","volume":"95","author":"D Langle","year":"2015","unstructured":"Langle D, Marquardt V, Heider E, Vigante B, Duburs G, Luntena I, et al. Design, synthesis and 3D-QSAR studies of novel 1,4-dihydropyridines as TGFbeta\/Smad inhibitors. Eur J Med Chem. 2015;95:249\u201366.","journal-title":"Eur J Med Chem"},{"issue":"11","key":"2853_CR38","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1016\/0028-3908(92)90015-H","volume":"31","author":"SJ Czuczwar","year":"1992","unstructured":"Czuczwar SJ, Gasior M, Janusz W, Kleinrok Z. Influence of flunarizine, nicardipine and nimodipine on the anticonvulsant activity of different antiepileptic drugs in mice. Neuropharmacology. 1992;31(11):1179\u201383.","journal-title":"Neuropharmacology."},{"issue":"17","key":"2853_CR39","doi-asserted-by":"crossref","first-page":"3J","DOI":"10.1016\/0002-9149(87)90206-2","volume":"59","author":"RL Whiting","year":"1987","unstructured":"Whiting RL. Animal pharmacology of nicardipine and its clinical relevance. Am J Cardiol. 1987;59(17):3J\u20138J.","journal-title":"Am J Cardiol"},{"issue":"15","key":"2853_CR40","doi-asserted-by":"crossref","first-page":"3H","DOI":"10.1016\/0002-9149(89)90973-9","volume":"64","author":"AD Michel","year":"1989","unstructured":"Michel AD, Whiting RL. Cellular action of nicardipine. Am J Cardiol. 1989;64(15):3H\u20137H.","journal-title":"Am J Cardiol"},{"issue":"3","key":"2853_CR41","doi-asserted-by":"crossref","first-page":"e91167","DOI":"10.1371\/journal.pone.0091167","volume":"9","author":"BR Huang","year":"2014","unstructured":"Huang BR, Chang PC, Yeh WL, Lee CH, Tsai CF, Lin C, et al. Anti-neuroinflammatory effects of the calcium channel blocker nicardipine on microglial cells: implications for neuroprotection. PLoS One. 2014;9(3):e91167.","journal-title":"PLoS One"},{"issue":"2\u20133","key":"2853_CR42","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.ejphar.2011.03.048","volume":"659","author":"C Bachmeier","year":"2011","unstructured":"Bachmeier C, Beaulieu-Abdelahad D, Mullan M, Paris D. Selective dihydropyiridine compounds facilitate the clearance of beta-amyloid across the blood-brain barrier. Eur J Pharmacol. 2011;659(2\u20133):124\u20139.","journal-title":"Eur J Pharmacol"},{"key":"2853_CR43","unstructured":"Anon. Nicardipine Hydrochloride Available from: https:\/\/dailymed.nlm.nih.gov\/dailymed\/fda\/fdaDrugXsl.cfm?setid=b8f147b8-955f-4733-9178-2cfa0beb60d6&type=display."},{"issue":"2","key":"2853_CR44","doi-asserted-by":"crossref","first-page":"27","DOI":"10.4103\/0976-0105.177703","volume":"7","author":"AB Nair","year":"2016","unstructured":"Nair AB, Jacob S. A simple practice guide for dose conversion between animals and human. J Basic Clin Pharm. 2016;7(2):27\u201331.","journal-title":"J Basic Clin Pharm"}],"container-title":["Pharmaceutical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11095-020-02853-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11095-020-02853-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11095-020-02853-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,10]],"date-time":"2021-06-10T23:46:22Z","timestamp":1623368782000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11095-020-02853-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6,11]]},"references-count":44,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2020,7]]}},"alternative-id":["2853"],"URL":"https:\/\/doi.org\/10.1007\/s11095-020-02853-5","relation":{},"ISSN":["0724-8741","1573-904X"],"issn-type":[{"value":"0724-8741","type":"print"},{"value":"1573-904X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,6,11]]},"assertion":[{"value":"9 November 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 June 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 June 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"127"}}